聚酯主动脉支架覆膜近端原位激光开窗术急诊治疗累及内脏与肾动脉的主动脉病变的中期结果
本研究分析了2015年8月至2020年12月连续44例因复杂腹主动脉瘤等病变接受聚酯主动脉支架覆膜近端原位激光开窗术(LFEVAR)的急诊治疗结果。技术成功率97%,30天死亡率4.5%(n=2),2年总生存率73%,主动脉相关再干预无生存率70%,支架相关再干预无生存率90.6%。作者认为该技术可行、安全,早中期结果满意,但为超说明书技术,需长期数据确认。
要点
- 聚酯主动脉支架覆膜近端原位激光开窗术急诊治疗复杂主动脉病变技术成功率97%,无中转开放手术。
- 30天死亡率为4.5%(n=2),未观察到脊髓缺血事件及早期支架相关并发症。
- 2年总生存率73%,主动脉相关再干预无生存率70%,支架相关再干预无生存率90.6%。
核心结论
- 聚酯主动脉支架覆膜近端原位激光开窗术对于累及内脏段的主动脉病变的非延期治疗是可行、安全的,并提供满意的早中期结果。
- 长期数据是确认这一有前景的超说明书技术实用性的必要条件。
研究设计与样本
- 回顾性分析2015年8月至2020年12月连续44例因复杂腹主动脉瘤等病变接受非延期聚酯主动脉支架覆膜近端原位激光开窗术(LFEVAR)的病例。
- 聚酯主动脉支架覆膜释放后使用旋切激光探头开窗,再用切割球囊和半顺应性球囊扩大开窗,随后在目标血管植入球囊扩张式桥接支架。
- 前瞻性收集中期生存率、通畅率和再干预率进行分析。
主要发现
- 44例手术的指征包括:11例1a型内漏、5例胸腹主动脉瘤、20例肾旁动脉瘤、4例节段性肾动脉保留、3例吻合口动脉瘤和1例主动脉夹层。
- 共完成108个激光开窗:肠系膜上动脉26个、腹腔干13个、右肾动脉33个、左肾动脉31个;中位缺血时间分别为7、48、48和45分钟。
- 技术成功率为97%,无中转开放手术;30天死亡率为4.5%(n=2);未观察到脊髓缺血事件及早期支架相关并发症。
- Kaplan-Meier 2年总生存率为73%,主动脉相关再干预无生存率为70%,支架相关再干预无生存率为90.6%。
- 中位随访24.7个月期间,检测到4例目标血管血栓形成(其中3例挽救成功),3例IIIc型内漏、1例肾动脉假性动脉瘤和1例肠系膜上动脉狭窄需要再干预。
局限性
- 作者指出长期数据是确认这一有前景的超说明书技术实用性的必要条件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Aortic endografting and antegrade in situ laser fenestration of visceral arteries (LFEVAR) may be considered as an alternative to open surgery for the emergency repair of complex abdominal aortic aneurysms (AAA) in fragile patients. The aim of this article was to evaluate the midterm results of LFEVAR performed with polyester endografts. METHODS: From August 2015 to December 2020, all consecutive LFEVAR performed for non-deferrable treatment of complex AAA were analysed. Polyester endografts were deployed and subsequently fenestrated using an atherectomy laser probe; the fenestrations were enlarged using cutting and semicompliant balloons before implantation of balloon expandable bridging stents into the target vessels. Prospectively collected midterm survival, patency, and re-intervention rates were analysed. RESULTS: Forty four procedures were performed for 11 type 1a endoleaks, five thoraco-abdominal aneurysms, 20 pararenal aneurysms, four segmental renal artery (RA) preservations, three anastomotic aneurysms, and one aortic dissection. One hundred and eight laser fenestrations were performed (26 for the superior mesenteric artery [SMA], 13 for the coeliac trunk, 33 and 31 for the right and left RA, respectively). The median ischaemia duration was 7, 48, 48, and 45 minutes, respectively. The technical success rate was 97%, with no open surgical conversions. The 30 day mortality was 4.5% (n = 2). No spinal cord ischaemia events were observed nor early stent related complications. Kaplan-Meier overall survival at two years was 73%, the aortic related re-intervention free survival was 70%, and the stent related re-intervention free survival was 90.6%. Four target vessel thromboses were detected, of which three were rescued. Three type IIIc endoleaks, one RA false aneurysm, and one SMA stenosis, required re-intervention during a median follow up of 24.7 months. CONCLUSION: Antegrade LFEVAR is feasible, safe, and provides satisfactory early and midterm outcomes for non-deferrable treatment of aortic pathologies involving the visceral segment. Long term data are mandatory to confirm the usefulness of this promising off label technique.
引用
- Le Houérou T, Álvarez-Marcos F, Gaudin A, et al. Midterm Outcomes of Antegrade In Situ Laser Fenestration of Polyester Endografts for Urgent Treatment of Aortic Pathologies Involving the Visceral and Renal Arteries. Eur J Vasc Endovasc Surg. 2023. PMID: 36731765. doi:10.1016/j.ejvs.2023.01.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。